Filana Therapeutics Inc (FLNA)

[runncoach]

If they don't, it seems likely they will fail top line results. Where it goes with the subgroup of mild patients is anyone's guess. They'll still have 500 or more in the mild groups to judge from but still will be viewed a failure by the usual suspects. I think Remi needs to make the market aware of the situation and any remedies the company may try to take involving recruitment at some point.